References
1.
Farman,
M., et al. . Fractal-fractional operator for COVID-19 (Omicron)
variant outbreak with analysis and modeling. RESULTS PHYS 39,
105630 (2022).
2.
Franch-Llasat,
D., et al. . Pneumococcal meningitis secondary to otitis media in
two patients with COVID-19 omicron variant. INT J EMERG MED 15,
50 (2022).
3.
Galloway,
S., Taunton, C., Matysek, R. & Hempenstall, A. Seeking to improve
access to COVID-19 therapeutics in the remote Torres and Cape
communities of Far North Queensland during the first COVID-19 omicron
outbreak. RURAL REMOTE HEALTH 22, 7657 (2022).
4.
Jing,
Y., et al. . Potential influence of COVID-19/ACE2 on the female
reproductive system. MOL HUM REPROD 26, 367-373 (2020).
5.
South,
A.M., Diz, D.I. & Chappell, M.C. COVID-19, ACE2, and the cardiovascular
consequences. AM J PHYSIOL-HEART C 318, H1084-H1090 (2020).
6.
Sui,
P., et al. . Pulmonary neuroendocrine cells amplify allergic
asthma responses. SCIENCE 360(2018).
7.
Carvelli,
J., et al. . Association of COVID-19 inflammation with activation
of the C5a-C5aR1 axis. NATURE 588, 146-150 (2020).
8.
Lamb,
L.E., et al. . COVID-19 inflammation results in urine cytokine
elevation and causes COVID-19 associated cystitis (CAC). MED
HYPOTHESES 145, 110375 (2020).
9.
Fernandez-Cruz,
A., et al. . A Retrospective Controlled Cohort Study of the Impact
of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.ANTIMICROB AGENTS CH 64(2020).
10.
Jiao,
X., et al. . A real-world study of glucocorticoid treatment in
COVID-19 patients with different disease severities. CLIN TRANSL
MED 10, e235 (2020).
11.
Thye,
A.Y., et al. . Psychological Symptoms in COVID-19 Patients:
Insights into Pathophysiology and Risk Factors of Long COVID-19.BIOLOGY-BASEL 11(2022).
12.
Martinez-Gomez,
L.E., et al. . ACE and ACE2 Gene Variants Are Associated With
Severe Outcomes of COVID-19 in Men. FRONT IMMUNOL 13, 812940
(2022).
13.
Khan,
W.H., et al. . COVID-19 Pandemic and Vaccines Update on Challenges
and Resolutions. FRONT CELL INFECT MI 11, 690621 (2021).
14.
Huang,
B., et al. . Substance P protects against hyperoxic-induced lung
injury in neonatal rats. EXP LUNG RES 41, 12-20 (2015).
15.
Wang,
N., et al. . Substance P-induced lung inflammation in mice is mast
cell dependent. CLIN EXP ALLERGY 52, 46-58 (2022).
16.
Lieb,
K., et al. . Effects of the neuropeptide substance P on sleep,
mood, and neuroendocrine measures in healthy young men.NEUROPSYCHOPHARMACOL 27, 1041-1049 (2002).
17.
Piedimonte,
G. Neural mechanisms of respiratory syncytial virus-induced inflammation
and prevention of respiratory syncytial virus sequelae. AM J RESP
CRIT CARE 163, S18-S21 (2001).